PMB Announces EIT Health Supported FLASHKNiFE Consortium Towar... - 01 June 2022 18:15

PEYNIER, France, June 1, 2022 /PRNewswire-AsiaNet/ -- PMB announces the launch of the FLASHKNiFE Consortium, supported by the European Institute of Innovation & Technology for Health (EIT Health). This European public-private partnership aims at advancing radiation therapy by introducing a new radiot...

  Tau-targeting Alzheimer's treatment, HMTM, moving toward regul... - 01 June 2022 18:00

SINGAPORE, June 1, 2022 /PRNewswire-AsiaNet/ -- - LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (HMTM) decline at a rate substantially less than is typical in Alzheimer's based on published research - Safety profile is favourable and consistent with previous HM...

  Winner Medical Announces to Acquire 55% Stake in Zhejiang Long... - 31 May 2022 14:12

SHENZHEN, China, May 31, 2022 /PRNewswire-AsiaNet/ -- On April 10 Winner Medical announced that it has signed a definitive agreement to acquire 55% stake in Zhejiang Longterm Medical Technology Co., Ltd. for US $108.2 million. Winner Medical believes that the acquisition aligns with the company's ...

  MedAlliance's SELUTION SLR Drug-Eluting Balloon (DEB) Receives... - 30 May 2022 09:00

GENEVA, May 30, 2022 /PRNewswire-AsiaNet/-- The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted "breakthro...

  Menarini inaugurates new regional headquarters in Dubai, UAE - 27 May 2022 00:34

DUBAI, UAE, May 26, 2022 /PRNewswire-AsiaNet/ -- The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across the Middle East and Africa (MEA) region with innovative products and breakthrough research Menarini, the leading Italian pharma...

  Pierre Fabre and EORTC open a large Phase III clinical study i... - 25 May 2022 16:15

CASTRES, France and BRUSSELS, May 24, 2022 /PRNewswire-AsiaNet/ -- - First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanoma - A global partnership between EORTC and Pierre Fabre to advance research in melanoma ...

  Insilico Medicine Announces Novel 3CL Protease Inhibitor Precl... - 25 May 2022 07:00

NEW YORK, May 25, 2022 /PRNewswire-AsiaNet/ -- -Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. -The candidate is intended to be used for the treatment of SARS-CoV-2 and its v...

  UAE powerhouse VPS Healthcare launches Burjeel Holdings to sca... - 24 May 2022 23:08

DAVOS, Switzerland, May 24, 2022 /PRNewswire-AsiaNet/ - On the sidelines of the World Economic Forum Annual Meeting, the UAE-based private healthcare services platform commits 50 pediatric stem cell transplantations to refugees of the Ukraine conflict The UAE-based VPS Healthcare has announc...

  Fullerton Health Chronicles COVID-19 Journey in E-book - 24 May 2022 20:03

SINGAPORE, May 24, 2022 /PRNewswire-AsiaNet/ -- Fullerton Health has today released 'The Mighty Storm - Fullerton Health Rises to the Challenge', a 68-page e-book that chronicles Fullerton Health's struggles, challenges and successes in support of the nation's two-year fight against the pandemi...

  OptraSCAN's Artificial Intelligence-Equipped Digital Pathology... - 24 May 2022 09:00

SAN JOSE, Calif., May 24, 2022 /PRNewswire-AsiaNet/ -- OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent - No 2020/0334814 A1 by the United States Patent and Trademark Off...